226 related articles for article (PubMed ID: 6591857)
21. A phase II study of mitoxantrone in advanced breast cancer.
Pronzato P; Ardizzoni A; Conte PF; Gulisano M; Lionetto R; Repetto L; Scornavacche V; Sertoli MR; Rosso R
Chemioterapia; 1986 Jun; 5(3):150-3. PubMed ID: 3719852
[TBL] [Abstract][Full Text] [Related]
22. [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].
Takagi T; Oguro M; Iwabuchi K
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1450-6. PubMed ID: 6588924
[TBL] [Abstract][Full Text] [Related]
23. Preliminary phase I study of 4'-epi-adriamycin.
Bonfante V; Bonadonna G; Villani F; Di Fronzo G; Martini A; Casazza AM
Cancer Treat Rep; 1979 May; 63(5):915-8. PubMed ID: 455333
[TBL] [Abstract][Full Text] [Related]
24. [Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--third report. Clinical Study Group of Adriamycin for Breast Cancer in Japan].
Yayoi E; Terasawa T; Koyama H; Sakai K; Kurokawa Y; Asaishi K; Morimoto T; Takashima S; Takatsuka Y; Yoshida K
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1873-80. PubMed ID: 3382239
[TBL] [Abstract][Full Text] [Related]
25. [Phase II study of mitoxantrone in advanced breast cancer].
Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
[TBL] [Abstract][Full Text] [Related]
26. [Recent contributions of chemotherapy to the treatment of breast cancer].
Focan C
Rev Med Liege; 1986 Mar; 41(5):158-64. PubMed ID: 3457413
[No Abstract] [Full Text] [Related]
27. An oriented phase II trial of THP-adriamycin in breast carcinoma.
Mathé G; Umezawa H; Oka S; Misset JL; Brienza S; de Vassal F; Musset M; Ribaud P; Tapiero H
Biomed Pharmacother; 1986; 40(10):376-9. PubMed ID: 3580506
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
Cowan JD; Osborne CK; Neidhart JA; Von Hoff DD; Constanzi JJ; Vaughn CB
Invest New Drugs; 1985; 3(2):149-52. PubMed ID: 3894277
[TBL] [Abstract][Full Text] [Related]
29. [Phase II study of (2''R)-4'-O-tetrahydropyranyldoxorubicin (THP) in patients with advanced gastrointestinal cancer--a report of the Tohoku THP Study Group].
Wakui A; Yokoyama M; Yoshida Y; Kikuchi Y; Osawa I; Masamune O; Matsuoka T; Sato S; Kikuchi K; Shoji T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1032-7. PubMed ID: 3963848
[TBL] [Abstract][Full Text] [Related]
30. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
31. [A randomized controlled study of maintenance therapy with (2"R)-4'-O-tetrahydropyranyladriamycin for advanced and recurrent breast cancer. Clinical Study Group of THP for Breast Cancer in Japan].
Enomoto K; Tominaga T; Abe R; Iino Y; Koyama H; Nomura Y; Abe O; Nakazato H
Gan To Kagaku Ryoho; 1996 Jun; 23(7):871-80. PubMed ID: 8678535
[TBL] [Abstract][Full Text] [Related]
32. [Two cases of recurrent gastrointestinal carcinoma treated with long-term THP].
Matsuzaki K; Toda T; Minamizono Y; Nagasaki S; Ezaki T; Miura O; Shimamura Y; Hamakubo S; Kan S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2987-92. PubMed ID: 3767387
[TBL] [Abstract][Full Text] [Related]
33. A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Bennett JM; Byrne P; Desai A; White C; DeConti R; Vogel C; Krementz E; Muggia F; Doroshow J; Plotkin D
Invest New Drugs; 1985; 3(2):179-85. PubMed ID: 3894279
[TBL] [Abstract][Full Text] [Related]
34. [Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--second report].
Sakai K; Yayoi E; Terasawa T; Koyama H; Takatsuka Y; Inoue K; Tominaga T; Yoshida K; Kurokawa Y; Watanabe H
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2301-8. PubMed ID: 6639092
[TBL] [Abstract][Full Text] [Related]
35. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
[TBL] [Abstract][Full Text] [Related]
36. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
[TBL] [Abstract][Full Text] [Related]
37. A phase of I trial of 4'-epi-Adriamycin.
Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.
Hirano S; Wakazono K; Agata N; Iguchi H; Tone H
Drugs Exp Clin Res; 1994; 20(4):153-60. PubMed ID: 7813387
[TBL] [Abstract][Full Text] [Related]
39. VP-16 and adriamycin in patients with advanced breast cancer.
Vaughn CB; Maniscalco-Greb E; Lockhard C; Groshko G; Enochs K; Duffin H; Demitrish M
Am J Clin Oncol; 1982 Oct; 5(5):505-9. PubMed ID: 6897491
[TBL] [Abstract][Full Text] [Related]
40. [Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].
Wada N; Kobayashi H; Oka S; Ando J; Tamura H
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1935-42. PubMed ID: 12465393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]